EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular epidemiology and in silico prediction of ciprofloxacin resistance in Salmonella enterica in Canada, 2017–2022

MacKenzie A P Wilke iD, Ketna Mistry, David Thumbi, Xiao Rui Li, Audrey Charlebois, Ashley C Cormier, Katrina Mickanuck, Brent P Avery, Colleen Murphy, Anne E Deckert, Ashley Kearney, Jennifer Campbell und 17 weitere

Canadian Journal of Microbiology · 2025

DOI: 10.1139/cjm-2024-0118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2025. Verfasst von MacKenzie A P Wilke und 28 weiteren Autor:innen. Beteiligte Einrichtung: National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Ciprofloxacin, Salmonella enterica, Anti-Bacterial Agents, Salmonella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genome Research and Development Initiative Shared Priority Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ciprofloxacin is important for treatment of severe or invasive Salmonella infections in humans. As laboratories transition from phenotypic to genomics-based methods for determining ciprofloxacin non-susceptibility, it is important to define the correlation between genetic determinants of resistance and phenotypic outcomes. Here, we examined ciprofloxacin resistance mechanisms in Salmonella and tested the hypothesis that isolates containing only one mechanism had intermediate resistance while isolates containing two or more mechanisms had full resistance according to breakpoints from the Clinical Laboratory Standards Institute. Among 13 750 human and food/animal Salmonella enterica isolates, 2325 were predicted to be non-susceptible to ciprofloxacin using whole genome sequencing and Staramr. The most common mechanisms of resistance were mutations in gyrA (especially S83F and D87N/D87Y) and the qnrB19 allele. Only 28% of ciprofloxacin resistant isolates had two or more resistance mechanisms; the remainder contained only one mechanism. Of isolates with two or more mechanisms, only 63% were resistant. Thus, the number of genetic determinants of ciprofloxacin resistance in an isolate could not reliably differentiate the ciprofloxacin intermediate or resistant categories when using North American breakpoints. Predicting ciprofloxacin intermediate/resistant as a single non-susceptible category would facilitate global standardization of data to inform public health surveillance, treatment guidelines, and stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CiprofloxacinSalmonella entericaAnti-Bacterial AgentsSalmonella InfectionsDrug Resistance, BacterialCanadaHumansMicrobial Sensitivity TestsMolecular EpidemiologyAnimalsComputer SimulationWhole Genome SequencingMutation

Stichwörter der Autor:innen

AMR predictionSalmonella entericaStaramrantimicrobial resistanceciprofloxacin

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB, Canada.
  • National Microbiology Laboratory Branch, Public Health Agency of Canada, Guelph, ON, Canada.
  • National Microbiology Laboratory Branch, Public Health Agency of Canada, St. Hyacinthe, QC, Canada.
  • Centre for Foodborne, Environmental and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON, Canada.
  • Shared Health, Winnipeg, MB, Canada.
  • Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.

ORCID-Profile: MacKenzie A P Wilke

Förderung

  • Genome Research and Development Initiative Shared Priority Project

Zitieren

APA

Wilke, M., Mistry, K., Thumbi, D., Li, X., Charlebois, A., Cormier, A., Mickanuck, K., Avery, B., Murphy, C., Deckert, A., Kearney, A., Campbell, J., Christianson, S., Alexander, D., El Bailey, S., Bekal, S., Chui, L., Ding, X., Dingle, T., …, & Bharat, A. (2025). Molecular epidemiology and in silico prediction of ciprofloxacin resistance in Salmonella enterica in Canada, 2017–2022. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2024-0118

Vancouver

Wilke M, Mistry K, Thumbi D, Li X, Charlebois A, Cormier A, et al. Molecular epidemiology and in silico prediction of ciprofloxacin resistance in Salmonella enterica in Canada, 2017–2022. Canadian Journal of Microbiology. 2025. doi:10.1139/cjm-2024-0118

BibTeX
@article{Wilke2025,
  author = {Wilke, MacKenzie A P and Mistry, Ketna and Thumbi, David and Li, Xiao Rui and Charlebois, Audrey and Cormier, Ashley C and Mickanuck, Katrina and Avery, Brent P and Murphy, Colleen and Deckert, Anne E and Kearney, Ashley and Campbell, Jennifer and Christianson, Sara and Alexander, David C and El Bailey, Sameh and Bekal, Sadjia and Chui, Linda and Ding, Xiaofeng and Dingle, Tanis C and Haldane, David and Hoang, Linda and Minion, Jessica and Patel, Samir and Zahariadis, George and Nadon, Celine and Mulvey, Michael R and Carson, Carolee A and Reid-Smith, Richard J and Bharat, Amrita},
  title = {Molecular epidemiology and in silico prediction of ciprofloxacin resistance in Salmonella enterica in Canada, 2017–2022},
  journal = {Canadian Journal of Microbiology},
  year = {2025},
  doi = {10.1139/cjm-2024-0118}
}
Kostenlos starten →